AKT1 and leukemia: The persistency of leukemia in vivo in Vav3-/- chimeras suggests that Vav3-/- BCR-ABL1 leukemia has evolved mechanisms of escape relying on RAC-independent pathways such as STAT3 signaling pathways (Supplementary Fig. S5B–D).